ArticleCancer medicine2014

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Kristin Skougaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.